337 related articles for article (PubMed ID: 18378241)
1. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
Wannamethee SG; Lennon L; Shaper AG
Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus.
Sluik D; Beulens JW; Weikert C; van Dieren S; Spijkerman AM; van der A DL; Fritsche A; Joost HG; Boeing H; Nöthlings U
Diabetes Metab Res Rev; 2012 Mar; 28(3):284-8. PubMed ID: 22144398
[TBL] [Abstract][Full Text] [Related]
5. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
6. gamma-Glutamyltransferase predicts cardiovascular death among Japanese women.
Hozawa A; Okamura T; Kadowaki T; Murakami Y; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Okayama A; Ueshima H;
Atherosclerosis; 2007 Oct; 194(2):498-504. PubMed ID: 17034795
[TBL] [Abstract][Full Text] [Related]
7. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
8. Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study.
Yi SW; Lee SH; Hwang HJ; Yi JJ
Atherosclerosis; 2017 Oct; 265():102-109. PubMed ID: 28881267
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.
Strasak AM; Kelleher CC; Klenk J; Brant LJ; Ruttmann E; Rapp K; Concin H; Diem G; Pfeiffer KP; Ulmer H;
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1857-65. PubMed ID: 18617645
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
Wannamethee SG; Shaper AG; Lennon L; Morris RW
Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
[TBL] [Abstract][Full Text] [Related]
11. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
12. Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
Wannamethee SG; Welsh P; Lennon L; Papacosta O; Whincup PH; Sattar N
Diabetologia; 2016 Sep; 59(9):1904-12. PubMed ID: 27312697
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
Wannamethee SG; Shaper AG; Lennon L
Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012
[TBL] [Abstract][Full Text] [Related]
14. Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events.
Wong ND; Gransar H; Shaw L; Polk D; Moon JH; Miranda-Peats R; Hayes SW; Thomson LE; Rozanski A; Friedman JD; Berman DS
JACC Cardiovasc Imaging; 2009 Mar; 2(3):319-26. PubMed ID: 19356578
[TBL] [Abstract][Full Text] [Related]
15. γ-Glutamyl Transferase as a Risk Factor for All-Cause or Cardiovascular Disease Mortality Among 5912 Ischemic Stroke.
Tu WJ; Liu Q; Cao JL; Zhao SJ; Zeng XW; Deng AJ
Stroke; 2017 Oct; 48(10):2888-2891. PubMed ID: 28904238
[TBL] [Abstract][Full Text] [Related]
16. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
17. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.
Lee DH; Silventoinen K; Hu G; Jacobs DR; Jousilahti P; Sundvall J; Tuomilehto J
Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study.
Wannamethee SG
Int J Obes (Lond); 2008 May; 32 Suppl 2():S25-9. PubMed ID: 18469839
[TBL] [Abstract][Full Text] [Related]
20. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Schindhelm RK; Dekker JM; Nijpels G; Bouter LM; Stehouwer CD; Heine RJ; Diamant M
Atherosclerosis; 2007 Apr; 191(2):391-6. PubMed ID: 16682043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
